Delivery Order SPE2DB20D9153-SPE2DB25FF21R
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $97,666.00 for Malarone 250-100 mg tablets (100 count) by the Defense Logistics Agency's Medical Supply Chain on July 30, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 31, 2025, carries no set-aside designation and will be performed at the contractor's facility in Park Ridge, Illinois. Malarone is an...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,077.96 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of 4563104610 - MALARONE 62.5-25 MG PED TAB 100S, with a performance period through December 12, 2023. This delivery order contract is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
- The Defense Logistics Agency Troop Support Medical has awarded a firm-fixed-price delivery order contract valued at $9,725.94 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This order is against DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 under the DLA's SPE2DB program, which has a potential total value of up to $4,999,999 through 2025. The current delivery order is for 4,563,723,318...
- This federal contract award, valued at $41,065.08, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of Malarone 250-100 mg tablets in quantities of 100. The contract does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,314.00 contract is for the delivery of Atovaquone-Proguanil 250-100 mg tablets, a malaria treatment medication, with a completion date of January 26, 2024. This delivery order falls under DMS Pharmaceutical Group's larger indefinite delivery vehicle (IDV) contract...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides for the delivery of Malarone 250-100 mg tablets to the Defense Logistics Agency (DLA) over a period ending on February 14, 2025. The $21,974.85 firm fixed-price delivery order is not associated with a set-aside designation. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,568,257,737 units of the pharmaceutical product MALARONE 250-100 MG TABLET 100S, with a ceiling value of $9,278.27 and a completion date of May 13, 2025. The contract is not designated as a set-aside. DMS Pharmaceutical Group Inc. holds a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $11,719.92, is for the delivery of 4,567,170,941 units of the prescription drug Malarone 250-100 mg tablet in 100-count packages. The contract has a performance period ending on February 6, 2025. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC)...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on July 29, 2025, for the supply of Atovaquone-Proguanil 250-100 tablets (100 count). This firm fixed-price delivery order, valued at $1,667.64, represents a single-line item procurement with a completion deadline of July 30, 2025. The award carries no set-aside designation, allowing the vendor to compete in...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,929.98 firm fixed-price delivery order is for the supply of atovaquone and proguanil, a prescription antimalarial medication. DMS Pharmaceutical Group holds a large $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to place delivery...
- SPE2DB20D9153Indefinite Delivery Contract
- SPE2DB20D9153-SPE2DB25FF21RDelivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,953.32 to DMS Pharmaceutical Group Inc. for the supply of Malarone 250-100 mg tablets (100-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its primary location. The contract was awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, and no set-aside designation was utilized in the competitive procurement process. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. The IDC, established under the SPE2DB program, enables the agency to issue firm fixed-price orders for pharmaceutical products supporting the medical supply requirements of military healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering prescription medications, biologics, and medical consumables to Department of Defense healthcare sites. The award of this Malarone delivery order reflects the contractor's continued role in providing essential antimalarial pharmaceutical products to support military personnel healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 8/19/25 |